Plecanatide vs Insulin Aspart
Head-to-head comparison of Plecanatide (Plecanatide) and Insulin Aspart (Insulin aspart (B28-Asp human insulin analog)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Plecanatide | Insulin Aspart |
|---|---|---|
| Category | Gastrointestinal | Diabetes & Metabolic |
| Full Name | Plecanatide | Insulin aspart (B28-Asp human insulin analog) |
| Molecular Weight | Approx. 1620 Da | 5825.8 Da |
| Half-Life | Local intestinal action; systemic half-life not clinically meaningful | About 1-3 hours |
| Amino Acids | 16 | 51 |
| Typical Dose | 3 mg once daily | 0.05-0.2 U/kg per meal |
| Route | Oral | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 350 | 11000 |
| Research Status | Clinical | Approved |
Plecanatide Benefits
- ✓improves-stool-frequency
- ✓supports-fluid-secretion
- ✓may-reduce-constipation
- ✓local-gut-action
Insulin Aspart Benefits
- ✓Fast post-meal glucose lowering
- ✓Predictable onset
- ✓Flexible mealtime administration
- ✓Compatible with pump therapy
Plecanatide Dosing
3 mg PO daily|take with or without food|avoid when dehydrated
Insulin Aspart Dosing
Inject SC immediately before meals|Titrate using glucose monitoring and carbohydrate intake|Can be used in insulin pumps or basal-bolus regimens
Plecanatide Side Effects
- ⚠diarrhea
- ⚠abdominal-discomfort
- ⚠nausea
Insulin Aspart Side Effects
- ⚠Hypoglycemia
- ⚠Injection-site reactions
- ⚠Weight gain
Research Overview
Plecanatide
Clinical trials show plecanatide improves constipation outcomes with a generally favorable tolerability profile. Like linaclotide, it acts locally in the intestinal lumen via GC-C signaling rather than systemic hormone effects.
Insulin Aspart
Research consistently shows faster onset and earlier peak action than regular human insulin. It is commonly studied for meal-time glycemic control and pump-based insulin delivery.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.